1. Home >
  2. M&A >
  3. Growth Capital >
  4. United States >
  5. New Jersey >
  6. Warburg Pincus Invests In Vertice Pharma

Investment Summary

Warburg Pincus Invests In Vertice Pharma

On November 17, 2015, private equity firm Warburg Pincus invested in life science company Vertice Pharma

Investment Highlights
  • This is Warburg Pincus’ 21st transaction in the Life Science sector.
  • This is Warburg Pincus’ 148th transaction in the United States.
  • This is Warburg Pincus’ 7th transaction in New Jersey.

Investment Summary
Date 2015-11-17
Target Vertice Pharma
Sector Life Science
Investor(s) Warburg Pincus
Deal Type Growth Capital
Advisor(s) Jefferies (Financial)

Target

Vertice Pharma

New Providence, New Jersey, United States
Vertice Pharma is a specialty pharmaceuticals company focused on improving patients’ health. Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Vertice Pharma is based in New Providence, New Jersey.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Warburg Pincus

New York, New York, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1966
PE ASSETS 83.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.

DEAL STATS #
Overall 288 of 492
Sector: Life Science M&A 21 of 27
Type: Growth Capital M&A Deals 89 of 159
State: New Jersey M&A 7 of 8
Country: United States M&A 148 of 241
Year: 2015 M&A 23 of 26
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-12 RegionalCare Hospital Partners

Brentwood, Tennessee, United States

RegionalCare Hospital Partners is an owner and operator of regional acute care facilities. RegionalCare Hospital Partners is based in Brentwood, Tennessee.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-19 Yodlee

Berwyn, Pennsylvania, United States

Yodlee specializes in open finance, data aggregation, and analytics solutions for financial institutions and fintech companies. Yodlee was founded in 1999 and is based in Redwood City, California.

Sell $660M
Mergr

Solution for

Product

Company

Legal